HPRA Drug Safety Newsletter highlights risks of Sodium Valproate
In the latest edition of their Drug Safety Newsletter, the Health Products Regulatory Authority (HPRA) have reminded healthcare professionals on their roles & responsibilities when it comes to prescribing & dispensing the epilepsy drug sodium valproate (Epilim).